US President Donald Trump announced a massive new trade policy on Thursday, declaring that the United States will impose tariffs of up to 100 per cent on imported branded and patented pharmaceutical products starting October 1. The move is explicitly designed to force drug manufacturing back onto American soil and could have significant repercussions for major foreign exporters, including Indian drugmakers.

US President Donald Trump rolled out a huge new trade policy on Thursday, saying that the United States will place tariffs of 100 per cent or more on imported branded and patented medicine products from October 1. The action is specifically aimed at compelling drug manufacturing back to American shores and has serious implications for big foreign exporters, including Indian pharma comp

See Full Page